▶ 調査レポート

エアロゾル療法の世界市場(~2026年)

• 英文タイトル:Global Aerosol Therapy Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。エアロゾル療法の世界市場(~2026年) / Global Aerosol Therapy Market Size, Status and Forecast 2020-2026 / MRC2-11QY13600資料のイメージです。• レポートコード:MRC2-11QY13600
• 出版社/出版日:QYResearch / 2020年11月30日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、99ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はエアロゾル療法のグローバル市場について調査・分析したレポートです。種類別(吸入器、ネブライザー、気管支拡張薬)市場規模、用途別(病院、診療所、外来手術センター、個人用)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別エアロゾル療法の競争状況、市場シェア
・世界のエアロゾル療法市場:種類別市場規模 2015年-2020年(吸入器、ネブライザー、気管支拡張薬)
・世界のエアロゾル療法市場:種類別市場規模予測 2021年-2026年(吸入器、ネブライザー、気管支拡張薬)
・世界のエアロゾル療法市場:用途別市場規模 2015年-2020年(病院、診療所、外来手術センター、個人用)
・世界のエアロゾル療法市場:用途別市場規模予測 2021年-2026年(病院、診療所、外来手術センター、個人用)
・北米のエアロゾル療法市場分析:米国、カナダ
・ヨーロッパのエアロゾル療法市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのエアロゾル療法市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のエアロゾル療法市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのエアロゾル療法市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Merck、Boehringer Ingelheim、GlaxoSmithKline、AstraZeneca、Novartis、Teva Pharmaceuticals、Opko Health、Omron Healthcare、Medtronic、GE Healthcare、Philips Healthcare、Agilent Technologies、GF Health Products
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices. This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.
Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.

Market Analysis and Insights: Global Aerosol Therapy Market
The global Aerosol Therapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Aerosol Therapy Scope and Market Size
Aerosol Therapy market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Aerosol Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Merck
Boehringer Ingelheim
GlaxoSmithKline
AstraZeneca
Novartis
Teva Pharmaceuticals
Opko Health
Omron Healthcare
Medtronic
GE Healthcare
Philips Healthcare
Agilent Technologies
GF Health Products

Market segment by Type, the product can be split into
Inhalers
Nebulizers
Bronchodilators
Market segment by Application, split into
Hospitals
Clinics
Ambulatory Surgical Centers
Individual

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Aerosol Therapy Revenue
1.4 Market by Type
1.4.1 Global Aerosol Therapy Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inhalers
1.4.3 Nebulizers
1.4.4 Bronchodilators
1.5 Market by Application
1.5.1 Global Aerosol Therapy Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Ambulatory Surgical Centers
1.5.5 Individual
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Aerosol Therapy Market Perspective (2015-2026)
2.2 Global Aerosol Therapy Growth Trends by Regions
2.2.1 Aerosol Therapy Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Aerosol Therapy Historic Market Share by Regions (2015-2020)
2.2.3 Aerosol Therapy Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Aerosol Therapy Market Growth Strategy
2.3.6 Primary Interviews with Key Aerosol Therapy Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Aerosol Therapy Players by Market Size
3.1.1 Global Top Aerosol Therapy Players by Revenue (2015-2020)
3.1.2 Global Aerosol Therapy Revenue Market Share by Players (2015-2020)
3.1.3 Global Aerosol Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Aerosol Therapy Market Concentration Ratio
3.2.1 Global Aerosol Therapy Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Aerosol Therapy Revenue in 2019
3.3 Aerosol Therapy Key Players Head office and Area Served
3.4 Key Players Aerosol Therapy Product Solution and Service
3.5 Date of Enter into Aerosol Therapy Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Aerosol Therapy Historic Market Size by Type (2015-2020)
4.2 Global Aerosol Therapy Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Aerosol Therapy Market Size by Application (2015-2020)
5.2 Global Aerosol Therapy Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Aerosol Therapy Market Size (2015-2020)
6.2 Aerosol Therapy Key Players in North America (2019-2020)
6.3 North America Aerosol Therapy Market Size by Type (2015-2020)
6.4 North America Aerosol Therapy Market Size by Application (2015-2020)

7 Europe
7.1 Europe Aerosol Therapy Market Size (2015-2020)
7.2 Aerosol Therapy Key Players in Europe (2019-2020)
7.3 Europe Aerosol Therapy Market Size by Type (2015-2020)
7.4 Europe Aerosol Therapy Market Size by Application (2015-2020)

8 China
8.1 China Aerosol Therapy Market Size (2015-2020)
8.2 Aerosol Therapy Key Players in China (2019-2020)
8.3 China Aerosol Therapy Market Size by Type (2015-2020)
8.4 China Aerosol Therapy Market Size by Application (2015-2020)

9 Japan
9.1 Japan Aerosol Therapy Market Size (2015-2020)
9.2 Aerosol Therapy Key Players in Japan (2019-2020)
9.3 Japan Aerosol Therapy Market Size by Type (2015-2020)
9.4 Japan Aerosol Therapy Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Aerosol Therapy Market Size (2015-2020)
10.2 Aerosol Therapy Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Aerosol Therapy Market Size by Type (2015-2020)
10.4 Southeast Asia Aerosol Therapy Market Size by Application (2015-2020)

11 India
11.1 India Aerosol Therapy Market Size (2015-2020)
11.2 Aerosol Therapy Key Players in India (2019-2020)
11.3 India Aerosol Therapy Market Size by Type (2015-2020)
11.4 India Aerosol Therapy Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Aerosol Therapy Market Size (2015-2020)
12.2 Aerosol Therapy Key Players in Central & South America (2019-2020)
12.3 Central & South America Aerosol Therapy Market Size by Type (2015-2020)
12.4 Central & South America Aerosol Therapy Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Merck
13.1.1 Merck Company Details
13.1.2 Merck Business Overview
13.1.3 Merck Aerosol Therapy Introduction
13.1.4 Merck Revenue in Aerosol Therapy Business (2015-2020))
13.1.5 Merck Recent Development
13.2 Boehringer Ingelheim
13.2.1 Boehringer Ingelheim Company Details
13.2.2 Boehringer Ingelheim Business Overview
13.2.3 Boehringer Ingelheim Aerosol Therapy Introduction
13.2.4 Boehringer Ingelheim Revenue in Aerosol Therapy Business (2015-2020)
13.2.5 Boehringer Ingelheim Recent Development
13.3 GlaxoSmithKline
13.3.1 GlaxoSmithKline Company Details
13.3.2 GlaxoSmithKline Business Overview
13.3.3 GlaxoSmithKline Aerosol Therapy Introduction
13.3.4 GlaxoSmithKline Revenue in Aerosol Therapy Business (2015-2020)
13.3.5 GlaxoSmithKline Recent Development
13.4 AstraZeneca
13.4.1 AstraZeneca Company Details
13.4.2 AstraZeneca Business Overview
13.4.3 AstraZeneca Aerosol Therapy Introduction
13.4.4 AstraZeneca Revenue in Aerosol Therapy Business (2015-2020)
13.4.5 AstraZeneca Recent Development
13.5 Novartis
13.5.1 Novartis Company Details
13.5.2 Novartis Business Overview
13.5.3 Novartis Aerosol Therapy Introduction
13.5.4 Novartis Revenue in Aerosol Therapy Business (2015-2020)
13.5.5 Novartis Recent Development
13.6 Teva Pharmaceuticals
13.6.1 Teva Pharmaceuticals Company Details
13.6.2 Teva Pharmaceuticals Business Overview
13.6.3 Teva Pharmaceuticals Aerosol Therapy Introduction
13.6.4 Teva Pharmaceuticals Revenue in Aerosol Therapy Business (2015-2020)
13.6.5 Teva Pharmaceuticals Recent Development
13.7 Opko Health
13.7.1 Opko Health Company Details
13.7.2 Opko Health Business Overview
13.7.3 Opko Health Aerosol Therapy Introduction
13.7.4 Opko Health Revenue in Aerosol Therapy Business (2015-2020)
13.7.5 Opko Health Recent Development
13.8 Omron Healthcare
13.8.1 Omron Healthcare Company Details
13.8.2 Omron Healthcare Business Overview
13.8.3 Omron Healthcare Aerosol Therapy Introduction
13.8.4 Omron Healthcare Revenue in Aerosol Therapy Business (2015-2020)
13.8.5 Omron Healthcare Recent Development
13.9 Medtronic
13.9.1 Medtronic Company Details
13.9.2 Medtronic Business Overview
13.9.3 Medtronic Aerosol Therapy Introduction
13.9.4 Medtronic Revenue in Aerosol Therapy Business (2015-2020)
13.9.5 Medtronic Recent Development
13.10 GE Healthcare
13.10.1 GE Healthcare Company Details
13.10.2 GE Healthcare Business Overview
13.10.3 GE Healthcare Aerosol Therapy Introduction
13.10.4 GE Healthcare Revenue in Aerosol Therapy Business (2015-2020)
13.10.5 GE Healthcare Recent Development
13.11 Philips Healthcare
10.11.1 Philips Healthcare Company Details
10.11.2 Philips Healthcare Business Overview
10.11.3 Philips Healthcare Aerosol Therapy Introduction
10.11.4 Philips Healthcare Revenue in Aerosol Therapy Business (2015-2020)
10.11.5 Philips Healthcare Recent Development
13.12 Agilent Technologies
10.12.1 Agilent Technologies Company Details
10.12.2 Agilent Technologies Business Overview
10.12.3 Agilent Technologies Aerosol Therapy Introduction
10.12.4 Agilent Technologies Revenue in Aerosol Therapy Business (2015-2020)
10.12.5 Agilent Technologies Recent Development
13.13 GF Health Products
10.13.1 GF Health Products Company Details
10.13.2 GF Health Products Business Overview
10.13.3 GF Health Products Aerosol Therapy Introduction
10.13.4 GF Health Products Revenue in Aerosol Therapy Business (2015-2020)
10.13.5 GF Health Products Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Aerosol Therapy Key Market Segments
Table 2. Key Players Covered: Ranking by Aerosol Therapy Revenue
Table 3. Ranking of Global Top Aerosol Therapy Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Aerosol Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Inhalers
Table 6. Key Players of Nebulizers
Table 7. Key Players of Bronchodilators
Table 8. Global Aerosol Therapy Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Aerosol Therapy Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Aerosol Therapy Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Aerosol Therapy Market Share by Regions (2015-2020)
Table 12. Global Aerosol Therapy Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Aerosol Therapy Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Aerosol Therapy Market Growth Strategy
Table 18. Main Points Interviewed from Key Aerosol Therapy Players
Table 19. Global Aerosol Therapy Revenue by Players (2015-2020) (Million US$)
Table 20. Global Aerosol Therapy Market Share by Players (2015-2020)
Table 21. Global Top Aerosol Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aerosol Therapy as of 2019)
Table 22. Global Aerosol Therapy by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Aerosol Therapy Product Solution and Service
Table 25. Date of Enter into Aerosol Therapy Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 28. Global Aerosol Therapy Market Size Share by Type (2015-2020)
Table 29. Global Aerosol Therapy Revenue Market Share by Type (2021-2026)
Table 30. Global Aerosol Therapy Market Size Share by Application (2015-2020)
Table 31. Global Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 32. Global Aerosol Therapy Market Size Share by Application (2021-2026)
Table 33. North America Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Aerosol Therapy Market Share (2019-2020)
Table 35. North America Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 36. North America Aerosol Therapy Market Share by Type (2015-2020)
Table 37. North America Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 38. North America Aerosol Therapy Market Share by Application (2015-2020)
Table 39. Europe Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Aerosol Therapy Market Share (2019-2020)
Table 41. Europe Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Aerosol Therapy Market Share by Type (2015-2020)
Table 43. Europe Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Aerosol Therapy Market Share by Application (2015-2020)
Table 45. China Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 46. China Key Players Aerosol Therapy Market Share (2019-2020)
Table 47. China Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 48. China Aerosol Therapy Market Share by Type (2015-2020)
Table 49. China Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 50. China Aerosol Therapy Market Share by Application (2015-2020)
Table 51. Japan Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Aerosol Therapy Market Share (2019-2020)
Table 53. Japan Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Aerosol Therapy Market Share by Type (2015-2020)
Table 55. Japan Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Aerosol Therapy Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Aerosol Therapy Market Share (2019-2020)
Table 59. Southeast Asia Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Aerosol Therapy Market Share by Type (2015-2020)
Table 61. Southeast Asia Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Aerosol Therapy Market Share by Application (2015-2020)
Table 63. India Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 64. India Key Players Aerosol Therapy Market Share (2019-2020)
Table 65. India Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 66. India Aerosol Therapy Market Share by Type (2015-2020)
Table 67. India Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 68. India Aerosol Therapy Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Aerosol Therapy Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Aerosol Therapy Market Share (2019-2020)
Table 71. Central & South America Aerosol Therapy Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Aerosol Therapy Market Share by Type (2015-2020)
Table 73. Central & South America Aerosol Therapy Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Aerosol Therapy Market Share by Application (2015-2020)
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Product
Table 78. Merck Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 79. Merck Recent Development
Table 80. Boehringer Ingelheim Company Details
Table 81. Boehringer Ingelheim Business Overview
Table 82. Boehringer Ingelheim Product
Table 83. Boehringer Ingelheim Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 84. Boehringer Ingelheim Recent Development
Table 85. GlaxoSmithKline Company Details
Table 86. GlaxoSmithKline Business Overview
Table 87. GlaxoSmithKline Product
Table 88. GlaxoSmithKline Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 89. GlaxoSmithKline Recent Development
Table 90. AstraZeneca Company Details
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Product
Table 93. AstraZeneca Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 94. AstraZeneca Recent Development
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Product
Table 98. Novartis Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 99. Novartis Recent Development
Table 100. Teva Pharmaceuticals Company Details
Table 101. Teva Pharmaceuticals Business Overview
Table 102. Teva Pharmaceuticals Product
Table 103. Teva Pharmaceuticals Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 104. Teva Pharmaceuticals Recent Development
Table 105. Opko Health Company Details
Table 106. Opko Health Business Overview
Table 107. Opko Health Product
Table 108. Opko Health Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 109. Opko Health Recent Development
Table 110. Omron Healthcare Business Overview
Table 111. Omron Healthcare Product
Table 112. Omron Healthcare Company Details
Table 113. Omron Healthcare Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 114. Omron Healthcare Recent Development
Table 115. Medtronic Company Details
Table 116. Medtronic Business Overview
Table 117. Medtronic Product
Table 118. Medtronic Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 119. Medtronic Recent Development
Table 120. GE Healthcare Company Details
Table 121. GE Healthcare Business Overview
Table 122. GE Healthcare Product
Table 123. GE Healthcare Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 124. GE Healthcare Recent Development
Table 125. Philips Healthcare Company Details
Table 126. Philips Healthcare Business Overview
Table 127. Philips Healthcare Product
Table 128. Philips Healthcare Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 129. Philips Healthcare Recent Development
Table 130. Agilent Technologies Company Details
Table 131. Agilent Technologies Business Overview
Table 132. Agilent Technologies Product
Table 133. Agilent Technologies Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 134. Agilent Technologies Recent Development
Table 135. GF Health Products Company Details
Table 136. GF Health Products Business Overview
Table 137. GF Health Products Product
Table 138. GF Health Products Revenue in Aerosol Therapy Business (2015-2020) (Million US$)
Table 139. GF Health Products Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Aerosol Therapy Market Share by Type: 2020 VS 2026
Figure 2. Inhalers Features
Figure 3. Nebulizers Features
Figure 4. Bronchodilators Features
Figure 5. Global Aerosol Therapy Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Clinics Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Individual Case Studies
Figure 10. Aerosol Therapy Report Years Considered
Figure 11. Global Aerosol Therapy Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Aerosol Therapy Market Share by Regions: 2020 VS 2026
Figure 13. Global Aerosol Therapy Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Aerosol Therapy Market Share by Players in 2019
Figure 16. Global Top Aerosol Therapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Aerosol Therapy as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Aerosol Therapy Revenue in 2019
Figure 18. North America Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Aerosol Therapy Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed